NCT03568929 Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma Status COMPLETED Phase N/A
NCT03558139 Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy Status COMPLETED Phase PHASE1
NCT03551522 A Study to Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH) Status TERMINATED Phase PHASE2
NCT03549312 Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy Status UNKNOWN Phase PHASE4
NCT03547973 Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread Status RECRUITING Phase PHASE2
NCT03547908 Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults Status COMPLETED Phase PHASE3
NCT03532425 B/F/TAF vs Atripla Double-Blind Switch Study in HIV-1 Infected Adults Status TERMINATED Phase PHASE4
NCT03512418 Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users (PrEPSteps) Status COMPLETED Phase PHASE3
NCT03502005 Efficacy, Safety & Tolerability of Switching EFV/TDF/FTC to BIC/FTC/TAF in Virologically Suppressed Adults With HIV-1 Status COMPLETED Phase PHASE4
NCT03498625 Crohn's Disease Endoscopic REmission Definition in an Objective Way Status COMPLETED Phase NA
NCT03493568 Switch From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inhibitor to E/C/F/TAF in Virologically Suppressed, HIV-1 Infected Patients (Be-OnE) Status TERMINATED Phase PHASE3
NCT03491553 Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B Status COMPLETED Phase PHASE2
NCT03487900 Is the Endoscopic Remission Evaluation, Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline, Predictive of Sustained Clinical Remission Using a 2-year Follow up Status UNKNOWN Phase NA
NCT03472950 Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT03472326 Study to Evaluate the Efficacy of GS-9131 Functional Monotherapy in Human Immunodeficiency Virus (HIV)-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing Regimen With Nucleos(t)Ide Reverse Transcriptase Inhibitor Resistant Virus Status TERMINATED Phase PHASE2
NCT03471624 Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF) Status COMPLETED Phase PHASE4
NCT03449446 Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) Status COMPLETED Phase PHASE2
NCT03442192 A Comparative Effectiveness Demonstration Project for Linkage and Retention in PrEP Care for Men Who Have Sex With Men Status TERMINATED Phase NA